Comments*

 
  • Academy Events

  • TAST 2011 — Thrombolysis and Acute Stroke Treatment in 2011: Preparing for the Next Decade

    December 1 - 3, 2011
    The New York Academy of Sciences

    Presented by the New York Academy of Sciences

    Designed to serve a multidisciplinary audience of physicians, clinicians, and scientists interested in cerebrovascular disease, this 2.5-day conference will explore the state-of-the-art and future directions of research and clinical practice leading to enhanced medical care in the acute treatment of ischemic stroke.

    The majority of strokes are due to thrombotic or thromboembolic blockage of an artery supplying the brain. Prompt treatment with thrombolytic agents can restore blood flow, limiting brain damage and improving recovery prognosis after ischemic stroke. Use of thrombolytic agents, including recombinant tissue-type plasminogen activator (rt-PA), over the past thirty years has enhanced patient outcomes, but has also highlighted many other aspects of the medical setting that impact treatment success. This symposium will explore these facets of acute intervention and a number of unaddressed issues related to the medical setting of stroke that provide opportunities for improving treatment. Following on ten previous international symposia on the theme of thrombolytic treatment in acute ischemic stroke (i.e. TTAST, TAST), the New York Academy of Sciences is proud to undertake the 11th meeting in this series (TAST 2011) to focus on these issues.

    The program will feature keynote and plenary lectures, short oral and poster presentations selected from abstract submissions, a mini-symposium, and a hands-on workshop on Advanced Multi-modal Neuroimaging and Ultrasound Techniques. There will be multiple opportunities for audience and panel discussion. Speakers will be asked to respond to sets of questions during their presentations to foster the generation of data-driven, multidisciplinary ideas, to explore ischemic stroke as a systemic disease related to other disease entities (hypertension, diabetes, and disorders of aging), and to better address the evolution of ischemic brain injury.

    Highlighted topics include: (i) the neurovascular unit and its injury; (ii) the safety and efficacy of thrombolytic agents currently used or being developed for acute stroke treatment; (iii) new views of the penumbra; (iv) time window considerations and optimized delivery conditions; (v) stabilization of brain tissue for patient recovery; (vi) enhancing the safety of plasminogen activators; (vii) factors that influence risk and benefit; and (viii) alternative approaches in stroke treatment.

    Live Webinar for Session II

    Session II: Clinical Management of Medical Issues in the Acute Setting will be broadcast via live webinar on December 2nd, 2:00–5:20 pm. You can register for this webinar by clicking the Register for Webinar link, above.

    Registration Pricing

      By: 11/30/2011 Onsite: 12/01/2011
    Member $350 $450
    Student / Postdoc / Fellow Member $175 $225
    Student / Postdoc / Fellow Nonmember $175 $225
    Nonmember Corporate $575 $675
    Nonmember Not for Profit $450 $550

     

    Registration for the conference includes the option to RSVP for the satellite workshop preceding the scientific sessions on December 1, 2011 from 1–5 pm, Advanced Multi-modal Neuroimaging and Ultrasound Approaches to Hyperacute Stroke Diagnosis, Treatment, and Monitoring, at no extra cost.
     
    Participants interested in this workshop only may register to attend only this satellite session at www.nyas.org/tast2011workshop.

     

    Scientific Co-Organizers

    Gregory J. del Zoppo, MD

    University of Washington School of Medicine

    Andrei V. Alexandrov, MD

    University of Alabama at Birmingham

    Scientific Advisory Committee

    Etsuro Mori, MD, PhD

    Tohoku University

    Markku Kaste, MD, PhD

    Helsinki University

    John R. Marler, MD

    Rockville, MD

    International Advisory Board

    Gudrun Boysen, MD

    University of Copenhagen

    Thomas G. Brott, MD

    The Mayo Clinic

    Alastair Buchan

    University of Oxford

    László Csiba, MD, PhD

    University of Debrecen

    Steven M. Davis, MD

    University of Melbourne

    Andrew Demchuk, MD

    University of Calgary

    Geoffrey Donnan, MD

    Florey Neuroscience Institutes

    Werner Hacke, MD, PhD

    University of Heidelberg

    Karsten Overgaard, MD

    University Hospital of Copenhagen, Gentofte Hospital

    Shirley Otis, MD

    Scripps Clinic–La Jolla

    Paul Trouillas, MD

    Hôpital Neurologique

    Lawrence Wong, MD, FRCP

    Chinese University of Hong Kong

    Take Yamaguchi, MD

    National Cardiovascular Center



    This meeting is part of our Translational Medicine Initiative, sponsored by the Josiah Macy Jr. Foundation and The Mushett Family Foundation.

     

    For a full list of sponsors, please view the Sponsors tab.

    EmailPrint